ArticleExperimental and therapeutic medicine2020

FGF9 promotes cisplatin resistance in colorectal cancer via regulation of Wnt/β-catenin signaling pathway.

Zhijin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.